The challenges of joint performance to method patents

檔案

本條目沒有附加檔案。

至出版者網站查看(DOI) ›

日期

2017

期刊名稱

EXPERT OPINION ON THERAPEUTIC PATENTS

卷期與頁次

第 27 卷第 4 期,頁 393–399

ISSN

1354-3776

語言

英文

摘要

Introduction: Biotech patents are facing increasingly stern challenges. The patent statue holds that a multi-step method patent is not directly infringed unless all steps are carried out and attributed to a single entity. When separate steps are performed jointly by two or more parties, those parties are liable for divided infringement if there exists a direct infringement. Possibilities thus exist for unauthorized but non-infringing joint performance, i. e. enforcing a method patent will be difficult if joint performance stands as a valid defense against direct infringement. Areas covered: This analysis covers issues on patent infringement, specifically on divided infringement of diagnostic and method patents. Expert opinion: A retrospective analysis indicates that a large number of cancer diagnostic patents issued during 2005-2014 are potentially vulnerable to read on unauthorized use in the manner of joint performance. Inventors should draft patent claims appropriately to reduce the risk to assert their patents in this regard.

所屬典藏

期刊論文
顯示完整詮釋資料 統計資料

引用此條目

Chen, F.-C. (2017). The challenges of joint performance to method patents. EXPERT OPINION ON THERAPEUTIC PATENTS, 27(4), 393–399. https://doi.org/10.1080/13543776.2017.1301930

BibTeX RIS

引用文字依 APA 第 7 版格式自動產生,使用前請再核對。

分享

永久網址:https://ir.lib.nycu.edu.tw/handle/11536/133213